organization · Reporting owner
DAG Ventures V, L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARMO BioSciences, Inc.
Report date January 30, 2018 · Filed January 30, 2018
Jointly reported with DAG Ventures Management V, LLC, DAG Ventures V-QP, L.P., Cadeddu John J., Goodrich R. Thomas
Section 16 reporting ended · disclosed 2018-01-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy DAG Ventures V-QP, L.P. | 2,397,908 |
Last balance in matching sequence
After 2018-01-30 transaction · row 9
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
5 source rowsRow 1 · 2018-01-30 · Conversion · Acquired 1,059,148 · Balance 1,059,148 F1: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 3 · 2018-01-30 · Conversion · Acquired 728,080 · Balance 1,787,228 F3: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 5 · 2018-01-30 · Conversion · Acquired 200,786 · Balance 1,988,014 F4: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 7 · 2018-01-30 · Conversion · Acquired 226,543 · Balance 2,214,557 F5: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 9 · 2018-01-30 · Conversion · Acquired 183,351 · Balance 2,397,908 F6: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy DAG Ventures V, L.P. | 5,838 |
Last balance in matching sequence
After 2018-01-30 transaction · row 10
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
5 source rowsRow 2 · 2018-01-30 · Conversion · Acquired 2,580 · Balance 2,580 F1: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 4 · 2018-01-30 · Conversion · Acquired 1,772 · Balance 4,352 F3: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 6 · 2018-01-30 · Conversion · Acquired 489 · Balance 4,841 F4: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 8 · 2018-01-30 · Conversion · Acquired 551 · Balance 5,392 F5: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Row 10 · 2018-01-30 · Conversion · Acquired 446 · Balance 5,838 F6: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V-QP, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-01-30 · Conversion · Disposed 1,059,148 · Balance 0 F1: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series A Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-01-30 · Conversion · Disposed 2,580 · Balance 0 F1: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V-QP, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-01-30 · Conversion · Disposed 728,080 · Balance 0 F3: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series B Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2018-01-30 · Conversion · Disposed 1,772 · Balance 0 F3: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series B-1 Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V-QP, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2018-01-30 · Conversion · Disposed 200,786 · Balance 0 F4: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series B-1 Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2018-01-30 · Conversion · Disposed 489 · Balance 0 F4: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V-QP, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2018-01-30 · Conversion · Disposed 226,543 · Balance 0 F5: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series C Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2018-01-30 · Conversion · Disposed 551 · Balance 0 F5: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series C-1 Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V-QP, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · 2018-01-30 · Conversion · Disposed 183,351 · Balance 0 F6: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
| Series C-1 Preferred StockSEC Table II · derivative / convertible security | IndirectBy DAG Ventures V, L.P. | 0 |
Reported balance
After 2018-01-30 transaction · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · 2018-01-30 · Conversion · Disposed 446 · Balance 0 F6: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date.
F2: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein.
F3: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date.
F4: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date.
F5: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date.
F6: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries C-1 Preferred Stock · Derivative | 446 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 20 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 0 Underlying: Common Stock · 446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F6 · derivative.exercise_date: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F6 · derivative.expiration_date: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries C-1 Preferred Stock · Derivative | 183,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 19 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 183,351 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F6 · derivative.exercise_date: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F6 · derivative.expiration_date: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries C Preferred Stock · Derivative | 551 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 18 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 0 Underlying: Common Stock · 551 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F5 · derivative.exercise_date: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F5 · derivative.expiration_date: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries C Preferred Stock · Derivative | 226,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 17 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 226,543 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F5 · derivative.exercise_date: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F5 · derivative.expiration_date: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries B-1 Preferred Stock · Derivative | 489 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 16 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 0 Underlying: Common Stock · 489 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F4 · derivative.exercise_date: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F4 · derivative.expiration_date: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries B-1 Preferred Stock · Derivative | 200,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 15 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 200,786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F4 · derivative.exercise_date: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F4 · derivative.expiration_date: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries B Preferred Stock · Derivative | 1,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 14 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F3 · derivative.exercise_date: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F3 · derivative.expiration_date: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries B Preferred Stock · Derivative | 728,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 13 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 728,080 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F3 · derivative.exercise_date: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F3 · derivative.expiration_date: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries A Preferred Stock · Derivative | 2,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 12 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 0 Underlying: Common Stock · 2,580 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionSeries A Preferred Stock · Derivative | 1,059,148 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · derivative · entry 11 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 0 Underlying: Common Stock · 1,059,148 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 446 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 10 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 5,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 183,351 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 9 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 2,397,908 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: Each share of the Issuer's Series C-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 551 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 8 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 5,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 226,543 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 7 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 2,214,557 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each share of the Issuer's Series C Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series C Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 489 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 6 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 4,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 200,786 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 5 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 1,988,014 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each share of the Issuer's Series B-1 Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B-1 Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 1,772 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 4 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 4,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 728,080 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 3 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 1,787,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each share of the Issuer's Series B Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series B Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 2,580 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 2 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V, L.P. Disclosed balance after: 2,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
| January 30, 2018 Filed Jan 30, 2018 17:32 UTC | ARMO BioSciences, Inc. ARMO · Entity 12201 | ConversionCommon Stock | 1,059,148 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-006068 · doc4.xml · nonDerivative · entry 1 DAG Ventures Management V, LLC · CIK 0001520913 · Former 10% owner DAG Ventures V-QP, L.P. · CIK 0001520911 · Former 10% owner DAG Ventures V, L.P. · CIK 0001520912 · Former 10% owner Cadeddu John J. · CIK 0001527931 · Former 10% owner Goodrich R. Thomas · CIK 0001527929 · Former 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By DAG Ventures V-QP, L.P. Disclosed balance after: 1,059,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock converted automatically into shares of the Issuer's Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering. The Series A Preferred Stock did not have an expiration date. F2 · ownership.nature: DAG Ventures Management V, LLC ("DAG Management V") serves as the sole General Partner of DAG Ventures V-QP, L.P. ("DAG V-QP") and DAG Ventures V, L.P. ("DAG V"). As such, DAG Management V possesses sole voting and investment control over the securities owned by DAG V-QP and DAG V, and may be deemed to have indirect beneficial ownership of the securities held by DAG V-QP and DAG V. DAG Management V, however, owns no securities of the Issuer directly. Messrs. Cadeddu and Goodrich are Managing Directors of DAG Management V and share voting and dispositive power over the shares held by DAG V-QP and DAG V. Each Reporting Person disclaims beneficial ownership of the shares held by DAG V-QP and DAG V except to the extent of his or its proportionate pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.